The DOI matches its Crossref record; the references it cites are not checked yet.
Current insights into the role of Fli-1 in hematopoiesis and malignant transformation
Open accessAbstract
Fli-1, a member of the ETS family of transcription factors, was discovered in 1991 through retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30 years, nearly 2000 papers have defined its biology and impact on normal development and cancer. In the hematopoietic system, Fli-1 controls self-renewal of stem cells and their differentiation into diverse mature blood cells. Fli-1 also controls endothelial survival and vasculogenesis, and high and low levels of Fli-1 are implicated in the auto-immune diseases systemic lupus erythematosus and systemic sclerosis, respectively. In addition, aberrant Fli-1 expression is observed in, and is essential for, the growth of multiple hematological malignancies and solid cancers. Here, we review the historical context and latest research on Fli-1, focusing on its role in hematopoiesis, immune response, and malignant transformation. The importance of identifying Fli-1 modulators (both agonists and antagonists) and their potential clinical applications is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fli1 is a key factor for Mk differentiation15, and for maintaining stemness in the stem and progenitor comparment76.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [76]
In the citing paper
“Fli1 is a key factor for Mk differentiation15, and for maintaining stemness in the stem and progenitor comparment76.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 112 · Cited by 54
Metadata
- Authors
- Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E.
- Affiliations
- Guiyang Medical University (CN)
- University Health Network (CA)
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2022-02-28
- Volume
- 79
- Issue
- 3
- Pages
- 163-163
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11072361
- OpenAlex
- W4223519368
- Cited by
- 54
- References
- 112
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 20 · 2023: 5 · 2022: 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (U1812403, 21867009)
- Guizhou Science and Technology Department (QKHPTRC[2019]5627)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- FLI1, ETS transcription factors, hematopoiesis, hematologic malignancies, malignant transformation, erythroleukemia, hematopoietic stem cell self-renewal, vasculogenesis, systemic lupus erythematosus, systemic sclerosis
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Leukemia, Erythroblastic, Acute, Hematopoiesis, Mice, Proto-Oncogene Protein c-fli-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. https://app.cochat.ai/papers/10.1007/s00018-022-04160-1
- The paper
- Ben-David, Y., Gajendran, B., Sample, K. M., & Zacksenhaus, E. (2022). Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-022-04160-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.